Medpace Holdings Inc buy UBS Group AG
Start price
15.02.24
/
50%
€369.50
Target price
15.02.25
€419.64
Performance (%)
-11.48%
End price
16.02.25
€327.10
Summary
This prediction ended on 16.02.25 with a price of €327.10. The price of Medpace Holdings Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.48%. UBS_Group_AG has a follow-up prediction for Medpace Holdings Inc, but this time predicts that Medpace Holdings Inc is a Sell. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Medpace Holdings Inc | 0.000% | 0.000% | 33.515% |
| iShares Core DAX® | -0.479% | -12.062% | -2.949% |
| iShares Nasdaq 100 | -3.377% | -5.130% | 9.585% |
| iShares Nikkei 225® | -0.143% | -12.633% | 20.316% |
| iShares S&P 500 | -2.266% | -5.049% | 5.803% |
Comments by UBS_Group_AG for this prediction
In the thread Medpace Holdings Inc diskutieren
Medpace Holdings, Inc. (NASDAQ: MEDP) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $452.00 price target on the stock, up previously from $282.00.
Ratings data for MEDP provided by MarketBeat
In the thread Trading Medpace Holdings Inc
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Medpace Holdings Inc
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€377.20
29.07.25
29.07.25
€263.00
29.07.26
29.07.26
3.82%
27.03.26
27.03.26
